| scholarly article | Q13442814 |
| P50 | author | Carlos López Otín | Q2919877 |
| Elías Campo | Q5830202 | ||
| Alfonso Valencia | Q16335154 | ||
| Pedro G. Ferreira | Q18686123 | ||
| Roderic Guigó i Serra | Q19720095 | ||
| Daniel Rico | Q51018374 | ||
| Sarah Djebali | Q55149993 | ||
| Guillem Clot | Q55445114 | ||
| Simone Ecker | Q57241367 | ||
| Jean Monlong | Q57241553 | ||
| Panagiotis Papasaikas | Q57241557 | ||
| Pedro Jares | Q58035979 | ||
| Marta Aymerich | Q60651570 | ||
| Armando López-Guillermo | Q88697793 | ||
| Neus Villamor | Q89017470 | ||
| Marta Gut | Q92883604 | ||
| Marta Kulis | Q117240563 | ||
| Magda Pinyol | Q117240573 | ||
| Alejandra Martínez-Trillos | Q117240574 | ||
| Mónica López-Guerra | Q117240576 | ||
| Núria López-Bigas | Q28737768 | ||
| Víctor Quesada | Q30423415 | ||
| Xose S. Puente | Q37391567 | ||
| José I Martín-Subero | Q39062643 | ||
| Dolors Colomer | Q43096016 | ||
| María Rozman | Q46821014 | ||
| David A Knowles | Q47327117 | ||
| Rory Johnson | Q47503855 | ||
| Gonzalo Gómez-López | Q47823939 | ||
| David G. Pisano | Q47823945 | ||
| P2093 | author name string | Ivo Gut | |
| Julie Blanc | |||
| David Tamborero | |||
| Cristina Royo | |||
| Maite Cazorla | |||
| Abel González-Pérez | |||
| Anaïs Gouin | |||
| P2860 | cites work | GENCODE: producing a reference annotation for ENCODE | Q21184138 |
| Finding community structure in very large networks | Q21686179 | ||
| Mapping and quantifying mammalian transcriptomes by RNA-Seq | Q22122035 | ||
| A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers | Q24318306 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers | Q24603754 | ||
| Integrative analysis of the melanoma transcriptome | Q24608060 | ||
| A coding-independent function of gene and pseudogene mRNAs regulates tumour biology | Q24632651 | ||
| Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia | Q24675399 | ||
| An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype | Q27339197 | ||
| Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation | Q27851655 | ||
| BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells. | Q53476669 | ||
| Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia | Q60197192 | ||
| Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts | Q27851675 | ||
| The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. | Q27851945 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Alternative isoform regulation in human tissue transcriptomes | Q27861118 | ||
| Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia | Q28255147 | ||
| Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling | Q28272891 | ||
| The GEM mapper: fast, accurate and versatile alignment by filtration | Q28278121 | ||
| POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia | Q28287338 | ||
| Repbase Update, a database of eukaryotic repetitive elements | Q29547460 | ||
| Landscape of transcription in human cells | Q29547467 | ||
| GenePattern 2.0 | Q29614171 | ||
| Transcriptome genetics using second generation sequencing in a Caucasian population | Q29614413 | ||
| Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia | Q29614659 | ||
| Frequent pathway mutations of splicing machinery in myelodysplasia | Q29616088 | ||
| L1 retrotransposition in human neural progenitor cells | Q29619265 | ||
| Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression | Q30156989 | ||
| Are clusters found in one dataset present in another dataset? | Q33239877 | ||
| The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas | Q33346593 | ||
| Analysis of gene expression data using BRB-ArrayTools. | Q33448521 | ||
| ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking | Q33896155 | ||
| Gitools: analysis and visualisation of genomic data using interactive heat-maps | Q33908215 | ||
| Thawing Frozen Robust Multi-array Analysis (fRMA) | Q34020892 | ||
| SF3B1 and other novel cancer genes in chronic lymphocytic leukemia | Q34093678 | ||
| Sparse inverse covariance estimation with the graphical lasso | Q34484010 | ||
| The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia | Q34542102 | ||
| The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation | Q35736854 | ||
| Estimation of alternative splicing variability in human populations | Q35791571 | ||
| RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings | Q35932349 | ||
| Sample-level enrichment analysis unravels shared stress phenotypes among multiple cancer types | Q36245197 | ||
| Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progression | Q36286867 | ||
| Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. | Q36369648 | ||
| 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data | Q36530107 | ||
| Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia | Q36637610 | ||
| FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia | Q36732806 | ||
| The impact of translocations and gene fusions on cancer causation | Q36760027 | ||
| Alternative splicing: an emerging topic in molecular and clinical oncology | Q36774636 | ||
| B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406. | Q37028635 | ||
| Chimeric transcript discovery by paired-end transcriptome sequencing | Q37257656 | ||
| A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia | Q37438957 | ||
| From pathogenesis to treatment of chronic lymphocytic leukaemia | Q37643423 | ||
| BioProfiling.de: analytical web portal for high-throughput cell biology | Q38490583 | ||
| Poly(ADP-ribosyl)ation links the chromatin remodeler SMARCA5/SNF2H to RNF168-dependent DNA damage signaling | Q39221344 | ||
| Alternative splicing of SYK regulates mitosis and cell survival | Q39546323 | ||
| RNA binding specificity of Unr, a protein with five cold shock domains | Q39727855 | ||
| Inhibition of proliferation and differentiation and promotion of apoptosis by cyclin L2 in mouse embryonic carcinoma P19 cells | Q39794284 | ||
| Spleen tyrosine kinase is overexpressed and represents a potential therapeutic target in chronic lymphocytic leukemia. | Q39834162 | ||
| Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A | Q42146150 | ||
| The lymphatic tissue microenvironments in chronic lymphocytic leukemia: in vitro models and the significance of CD40-CD154 interactions | Q42389003 | ||
| Grape RNA-Seq analysis pipeline environment. | Q42773581 | ||
| Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20. | Q43860255 | ||
| Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. | Q50932977 | ||
| P433 | issue | 2 | |
| P921 | main subject | transcriptome | Q252857 |
| lymphocyte | Q715347 | ||
| leukemia | Q29496 | ||
| RNA sequencing | Q2542347 | ||
| P304 | page(s) | 212-226 | |
| P577 | publication date | 2013-11-21 | |
| P1433 | published in | Genome Research | Q5533485 |
| P1476 | title | Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia | |
| P478 | volume | 24 |
| Q61804894 | A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion |
| Q37482750 | A ribosome-related signature in peripheral blood CLL B cells is linked to reduced survival following treatment. |
| Q30768193 | ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial. |
| Q34044691 | Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes |
| Q42371573 | Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia |
| Q38611244 | B cell receptor signaling regulates metabolism in Chronic Lymphocytic Leukemia |
| Q33732992 | CEBPA-mediated upregulation of the lncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt/β-catenin signaling pathways |
| Q90160285 | CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation |
| Q37480308 | Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance |
| Q31152527 | ChimPipe: accurate detection of fusion genes and transcription-induced chimeras from RNA-seq data |
| Q33862792 | Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks |
| Q93039099 | Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL |
| Q97542399 | Chromatin network markers of leukemia |
| Q56270980 | Chronic lymphocytic leukaemia |
| Q38708220 | Chronic lymphocytic leukemia: Time to go past genomics? |
| Q64123404 | Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia |
| Q30992577 | Clustering of Expression Data in Chronic Lymphocytic Leukemia Reveals New Molecular Subdivisions |
| Q35863265 | Comparison of RNA-seq and microarray-based models for clinical endpoint prediction |
| Q38769301 | Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes |
| Q52727954 | Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia. |
| Q37130889 | DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia |
| Q42007720 | Design of Biomedical Robots for Phenotype Prediction Problems. |
| Q35653850 | Developing Molecular Signatures for Chronic Lymphocytic Leukemia |
| Q38712211 | Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1. |
| Q37609524 | Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features |
| Q47331796 | Drug-perturbation-based stratification of blood cancer |
| Q92881078 | EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia |
| Q49687100 | Epigenetic and Transcriptional Variability Shape Phenotypic Plasticity. |
| Q40042893 | Evolving DNA methylation and gene expression markers of B-cell chronic lymphocytic leukemia are present in pre-diagnostic blood samples more than 10 years prior to diagnosis |
| Q38232481 | Evolving understanding of the CLL genome |
| Q36432485 | Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targeting |
| Q47784889 | Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer |
| Q35810815 | Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens |
| Q47134267 | Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia |
| Q34540109 | GeneSCF: a real-time based functional enrichment tool with support for multiple organisms |
| Q37637724 | Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia |
| Q28087672 | Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia |
| Q38797514 | Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance |
| Q31147488 | Genomic data integration in chronic lymphocytic leukemia. |
| Q37336849 | Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL. |
| Q60919331 | Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia |
| Q38418199 | High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review |
| Q35021249 | Higher gene expression variability in the more aggressive subtype of chronic lymphocytic leukemia |
| Q56989154 | Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations |
| Q36520447 | Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments. |
| Q37222108 | Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas. |
| Q36343345 | Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study. |
| Q58725483 | Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy |
| Q41694305 | Long non-coding RNAs in B-cell malignancies: a comprehensive overview. |
| Q92890447 | Methylation alteration of SHANK1 as a predictive, diagnostic and prognostic biomarker for chronic lymphocytic leukemia |
| Q37478622 | MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer |
| Q56992548 | Mobile Elements in the Human Genome: Implications for Disease |
| Q36849273 | Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing |
| Q38335695 | Molecular pathogenesis of CLL and its evolution |
| Q91387291 | Multiplexed profiling of RNA and protein expression signatures in individual cells using flow or mass cytometry |
| Q37588101 | NEK2 serves as a prognostic biomarker for hepatocellular carcinoma |
| Q56996904 | Non-coding recurrent mutations in chronic lymphocytic leukaemia |
| Q48222706 | Overexpression of the proneural transcription factor ASCL1 in chronic lymphocytic leukemia with a t(12;14)(q23.2;q32.3). |
| Q28076200 | Pharmacogenetics and pharmacogenomics as tools in cancer therapy |
| Q35775566 | Proteins interaction network and modeling of IGVH mutational status in chronic lymphocytic leukemia |
| Q49788400 | Proteomics profiling of CLL versus healthy B-cells identifies putative therapeutic targets and a subtype-independent signature of spliceosome dysregulation. |
| Q98164535 | RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia |
| Q38872127 | RPPA-based protein profiling reveals eIF4G overexpression and 4E-BP1 serine 65 phosphorylation as molecular events that correspond with a pro-survival phenotype in chronic lymphocytic leukemia |
| Q61810422 | Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia |
| Q39326147 | Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma |
| Q34601323 | Sample processing obscures cancer-specific alterations in leukemic transcriptomes. |
| Q60918238 | Sex-related DNA methylation differences in B cell chronic lymphocytic leukemia |
| Q55353370 | Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. |
| Q57029282 | Splicing modulation sensitizes chronic lymphocytic leukemia cells to venetoclax by remodeling mitochondrial apoptotic dependencies |
| Q33967993 | The RIDL hypothesis: transposable elements as functional domains of long noncoding RNAs |
| Q38826234 | The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1. |
| Q38597740 | The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells |
| Q43201179 | The YPEL5-PPP1CB fusion transcript is detected in different hematological malignancies and in normal samples. |
| Q38286344 | The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications |
| Q44290485 | The impact of SF3B1 mutations in CLL on the DNA-damage response |
| Q34334347 | The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression |
| Q36410173 | The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches |
| Q57090272 | The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q30395427 | The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia. |
| Q64266485 | Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns |
| Q35577014 | Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancers |
| Q38732657 | Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia |
| Q38822886 | lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome |
| Q43162081 | miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL. |
Search more.